Hepatitis B and C in institutions for individuals with intellectual disability

Citation
A. Vellinga et al., Hepatitis B and C in institutions for individuals with intellectual disability, J INTEL DIS, 43, 1999, pp. 445-453
Citations number
77
Categorie Soggetti
Rehabilitation,"Neurosciences & Behavoir
Journal title
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH
ISSN journal
09642633 → ACNP
Volume
43
Year of publication
1999
Part
6
Pages
445 - 453
Database
ISI
SICI code
0964-2633(199912)43:<445:HBACII>2.0.ZU;2-6
Abstract
People with intellectual disability are a well-known highrisk group for hep atitis B virus (HBV) infection. Hepatitis B virus is a major public health problem, but it is often neglected because of its largely asymptomatic cour se with long-term complications. Safe and effective vaccines have been avai lable for over 15 years. However, universal vaccination strategies have not or have not completely been implemented to date, even though epidemiologic al data have indicated the effectiveness and efficacy of vaccination, and e conomic evaluations have shown that it is cost effective. Hepatitis C virus (HCV), which was discovered in 1989, has similar risk factors and is also a cause of chronic hepatitis. The prevalence of HCV amongst individuals wit h intellectual disability has not been clearly established. An overview of the literature on the prevalence of HBV and HCV in this population, as well as risk factors, transmission and prevention is presented in the present r eview. The literature cited in the present article was obtained by searches in MedLine using the following keywords and keyword combinations: hepatiti s, hepatitis B virus, hepatitis C virus, mentally retarded, mentally handic apped, developmentally retarded, intellectual disability, institutionalizat ion, Down's syndrome and hepatitis B vaccination. The search was done from 1980 to 1998. Beside this, the older articles found in the references were included if these were considered necessary for completeness.